These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 26733157)

  • 61. Epigenetic alteration of imprinted genes during neural differentiation of germline-derived pluripotent stem cells.
    Lee HJ; Choi NY; Lee SW; Ko K; Hwang TS; Han DW; Lim J; Schöler HR; Ko K
    Epigenetics; 2016 Mar; 11(3):177-83. PubMed ID: 26962997
    [TBL] [Abstract][Full Text] [Related]  

  • 62. BMI1, ALDH1A1, and CD133 Transcripts Connect Epithelial-Mesenchymal Transition to Cancer Stem Cells in Lung Carcinoma.
    Koren A; Rijavec M; Kern I; Sodja E; Korosec P; Cufer T
    Stem Cells Int; 2016; 2016():9714315. PubMed ID: 26770215
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Priming strategies for controlling stem cell fate: Applications and challenges in dental tissue regeneration.
    Zhang SY; Ren JY; Yang B
    World J Stem Cells; 2021 Nov; 13(11):1625-1646. PubMed ID: 34909115
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Development of a High-Efficacy Reprogramming Method for Generating Human Induced Pluripotent Stem (iPS) Cells from Pathologic and Senescent Somatic Cells.
    Tanaka N; Kato H; Tsuda H; Sato Y; Muramatsu T; Iguchi A; Nakajima H; Yoshitake A; Senbonmatsu T
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32942642
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Retention of Somatic Memory Associated with Cell Identity, Age and Metabolism in Induced Pluripotent Stem (iPS) Cells Reprogramming.
    Khoo TS; Jamal R; Abdul Ghani NA; Alauddin H; Hussin NH; Abdul Murad NA
    Stem Cell Rev Rep; 2020 Apr; 16(2):251-261. PubMed ID: 32016780
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Reprogramming of mouse fibroblasts into induced pluripotent stem cells with Nanog.
    Moon JH; Yun W; Kim J; Hyeon S; Kang PJ; Park G; Kim A; Oh S; Whang KY; Kim DW; Yoon BS; You S
    Biochem Biophys Res Commun; 2013 Feb; 431(3):444-9. PubMed ID: 23333380
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Overexpression Nanog activates pluripotent genes in porcine fetal fibroblasts and nuclear transfer embryos.
    Zhang L; Luo YB; Bou G; Kong QR; Huan YJ; Zhu J; Wang JY; Li H; Wang F; Shi YQ; Wei YC; Liu ZH
    Anat Rec (Hoboken); 2011 Nov; 294(11):1809-17. PubMed ID: 21972213
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Generation of human-induced pluripotent stem cells from gut mesentery-derived cells by ectopic expression of OCT4/SOX2/NANOG.
    Li Y; Zhao H; Lan F; Lee A; Chen L; Lin C; Yao Y; Li L
    Cell Reprogram; 2010 Jun; 12(3):237-47. PubMed ID: 20698766
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Nanog induces hyperplasia without initiating tumors.
    Fischedick G; Wu G; Adachi K; Araúzo-Bravo MJ; Greber B; Radstaak M; Köhler G; Tapia N; Iacone R; Anastassiadis K; Schöler HR; Zaehres H
    Stem Cell Res; 2014 Sep; 13(2):300-15. PubMed ID: 25173648
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Ectopic overexpression of Nanog induces tumorigenesis in non-tumorous fibroblasts.
    Park YS; Nemeño JG; Choi NY; Lee JI; Ko K; Choi SC; Kim WS; Han DW; Tapia N; Ko K
    Biol Chem; 2016 Mar; 397(3):249-55. PubMed ID: 26733157
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Regulation of NANOG in cancer cells.
    Gong S; Li Q; Jeter CR; Fan Q; Tang DG; Liu B
    Mol Carcinog; 2015 Sep; 54(9):679-87. PubMed ID: 26013997
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The role of NANOG transcriptional factor in the development of malignant phenotype of cancer cells.
    Gawlik-Rzemieniewska N; Bednarek I
    Cancer Biol Ther; 2016; 17(1):1-10. PubMed ID: 26618281
    [TBL] [Abstract][Full Text] [Related]  

  • 73.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.